121 related articles for article (PubMed ID: 23221606)
1. Immunohistochemical analysis for therapeutic targets and prognostic markers in low-grade endometrial stromal sarcoma.
Park JY; Kim KR; Nam JH
Int J Gynecol Cancer; 2013 Jan; 23(1):81-9. PubMed ID: 23221606
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Characterization of Histone Deacetylase as a Potential Prognostic Marker and Therapeutic Target in Endometrial Stromal Sarcoma.
Baek MH; Park JY; Rhim CC; Park Y; Kim KR; Kim JH; Nam JH
Anticancer Res; 2016 May; 36(5):2527-34. PubMed ID: 27127168
[TBL] [Abstract][Full Text] [Related]
3. Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.
Park JY; Baek MH; Park Y; Kim YT; Nam JH
Virchows Arch; 2018 Jul; 473(1):61-69. PubMed ID: 29869299
[TBL] [Abstract][Full Text] [Related]
4. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
[TBL] [Abstract][Full Text] [Related]
5. Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.
Agarwal R; Rajanbabu A; Nair IR; Satish C; Jose G; Unikrishnan UG
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():92-97. PubMed ID: 28738297
[TBL] [Abstract][Full Text] [Related]
6. Transition from low-grade endometrial stromal sarcoma to high-grade endometrial stromal sarcoma.
Ohta Y; Suzuki T; Omatsu M; Hamatani S; Shiokawa A; Kushima M; Ota H
Int J Gynecol Pathol; 2010 Jul; 29(4):374-7. PubMed ID: 20567152
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal low grade endometrial stromal sarcoma with florid endometrioid glandular differentiation: Cytologic-histologic correlation and differential diagnosis.
Abdelkader A; Giorgadze T
Ann Diagn Pathol; 2019 Apr; 39():25-29. PubMed ID: 30611894
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of low-grade endometrial stromal sarcoma indicates fusion protein-mediated activation of the Wnt signaling pathway.
Przybyl J; Kidzinski L; Hastie T; Debiec-Rychter M; Nusse R; van de Rijn M
Gynecol Oncol; 2018 May; 149(2):388-393. PubMed ID: 29544705
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of uterine and extrauterine low-grade endometrial stromal sarcoma: an observational cohort study.
Dai Q; Xu B; Wu H; You Y; Li L
Int J Surg; 2024 Apr; 110(4):1919-1928. PubMed ID: 38329091
[TBL] [Abstract][Full Text] [Related]
10. Investigation of New Therapeutic Targets in Undifferentiated Endometrial Sarcoma.
Baek MH; Park JY; Rhim CC; Kim JH; Park Y; Kim KR; Nam JH
Gynecol Obstet Invest; 2017; 82(4):329-339. PubMed ID: 28125812
[TBL] [Abstract][Full Text] [Related]
11. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?
Feng W; Malpica A; Skaland I; Gudlaugsson E; Robboy SJ; Dalen I; Hua K; Zhou X; Baak JP
PLoS One; 2013; 8(10):e75899. PubMed ID: 24146786
[TBL] [Abstract][Full Text] [Related]
12. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
[TBL] [Abstract][Full Text] [Related]
13. MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus.
Popiolek D; Yee H; Levine P; Vamvakas E; Demopoulos RI
Gynecol Oncol; 2003 Aug; 90(2):353-7. PubMed ID: 12893199
[TBL] [Abstract][Full Text] [Related]
14. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT
Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684
[TBL] [Abstract][Full Text] [Related]
15. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features and prognostic factors of endometrial stromal sarcoma: a study of 55 cases].
Shi JL; Cheng NH; Guo LN; Lian LJ
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):517-22. PubMed ID: 22169638
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of endometrial stromal sarcoma from an academic medical hospital in China.
Jin Y; Pan L; Wang X; Dai Z; Huang H; Guo L; Shen K; Lian L
Int J Gynecol Cancer; 2010 Dec; 20(9):1535-9. PubMed ID: 21370596
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow.
Schindlbeck C; Hantschmann P; Zerzer M; Jahns B; Rjosk D; Janni W; Rack B; Sommer H; Friese K
Int J Gynecol Cancer; 2007; 17(5):1047-55. PubMed ID: 17433065
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
[TBL] [Abstract][Full Text] [Related]
20. [Clinical review of 97 patients with endometrial stromal sarcoma].
Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
